复元活血汤联合西药预防麦默通手术出血的疗效及对患者术后疼痛的影响

目的 探讨复元活血汤联合西药预防麦默通手术出血的临床疗效,以及对患者术后疼痛的影响。 方法 选取2016年6月-2017年10月期间在温州市中医院行麦默通乳腺结节微创旋切术的80例女性患者为研究对象,根据简单随机化分组方式(1:1)将其分为对照组和观察组,每组各40例。对照组给予弹力绷带加压包扎48 h处理和止血药静滴等常规干预,观察组在对照组基础上,术前3 d联合复元活血汤预防治疗。比较2组手术时间、术中出血量、住院时间和费用等基本情况,观察术后疼痛视觉模拟评分(VAS)和相关并发症发生情况。 结果 2组患者均成功完成手术,无中途退出病例。观察组手术出血量(5.1±1.5)ml]、住院天数(2.1±1.6)d]、住院费用(8 970.2±921.3)元]分别较对照组低出血量(6.8±1.7)ml、住院天数(4.1±1.1)d、(9 452.6±845.2)元],差异具有统计学意义(均P<0.05);观察组术后血肿发生率为2.50%(1/40),显著低于对照组的22.50%(9/40),差异具有统计学意义(P<0.05);观察组术后2、3 d的VAS评分(3.2±1.0)分、(2.5±0.9)分]分别比对照组低(3.8±1.2)分、(3.1±1.1)分],差异具有统计学意义(P<0.05)。 结论 复元活血汤有助于减少麦默通手术出血和降低血肿并发症风险,减轻患者生理疼痛和住院费用,临床应用价值显著。 

Effect of Fuyuan Huoxue Decoction combined with western medicine on preventing hemorrhage after mammotome operation and its effect on postoperative pain

Objective To investigate the effect of Fuyuan Huoxue Decoction Combined with western medicine on preventing hemorrhage after mammotome operation and its effect on postoperative pain, so as to improve the clinical effect of benign breast swelling. Methods In this study, 80 women with mammotome breast nodules in our hospital during the period of June, 2016 to October, 2017 were selected as the subjects. According to the simple randomization group (1:1), they were divided into the control group and the observation group, and the two groups were 40 cases each. The control group was given the elastic bandage pressure thin wrapping 48 h treatment and the static drip of hemostatic medicine. On the basis of the control group, the observation group was treated with 3D combined with Fuyuan Huoxue Decoction. The operation time, the amount of bleeding, the time of hospitalization and the cost of the two groups were compared, and the postoperative pain visual analogue score (VAS) and the related complications were observed. Results Two groups of patients were successfully completed surgery, no withdrawal case. The amount of operation bleeding(5.1±1.5) ml], hospital days(3.4±1.3) days] and hospitalization expenses(8 970.2±921.3) yuan] were lower than that of the control group(6.8±1.7) ml], hospitalization days(4.1±1.1) days] and(9 452.6±845.2) yuan], and the difference was statistically significant (P<0.05). The postoperative hematoma rate 2.50% (1/40) was significantly lower in the observation group. The difference was statistically significant in the control group 22.50% (9/40), and the difference was statistically significant (P<0.05). The VAS scores of 2D and 3D(3.2±1.0) and (2.5±0.9)] in the observation group were lower than those of the control group(3.8 ±1.2) and (3.1± 1.1)] respectively, and the difference was statistically significant (P<0.05). Conclusion Fuyuan Huoxue Decoction can help reduce the risk of bleeding and complication of hematoma, reduce the patient's physical pain and hospitalization expenses, and the clinical application value is remarkable.